Opus Genetics, Inc. (ticker: IRD) is a clinical-stage biotechnology company. Based on the limited text provided from this 10-K filing, the company operates in the genetics/ophthalmology space. The filing does not provide sufficient detail in the extracted section to fully describe specific products or services beyond the company name and general SEC filing structure.
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001140361-26-009247 | EDGAR | 100K words |
| 2025-03-31 | 2024-12-31 | 0001140361-25-011410 | EDGAR | — |
| 2024-03-08 | 2023-12-31 | 0001140361-24-012399 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001140361-23-014868 | EDGAR | — |
| 2022-03-24 | 2021-12-31 | 0001140361-22-011015 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001140361-21-008099 | EDGAR | — |
| 2020-02-21 | 2019-12-31 | 0001140361-20-003785 | EDGAR | — |
| 2019-03-07 | 2018-12-31 | 0001140361-19-004539 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001140361-18-012817 | EDGAR | — |
| 2017-02-24 | 2016-12-31 | 0001140361-17-009132 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001140361-25-041547 | EDGAR | 34K words |
| 2025-08-13 | 2025-06-30 | 0001140361-25-030836 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001140361-25-019266 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001140361-24-046045 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001140361-24-037068 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001140361-24-025481 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001140361-23-052749 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001140361-23-039196 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001140361-23-024504 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0001140361-22-040029 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001140361-22-029461 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001140361-22-019002 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-10 | 0001140361-26-008621 | EDGAR | 3K words |
| 2026-02-19 | 0001140361-26-006176 | EDGAR | — |
| 2026-01-12 | 0001140361-26-000913 | EDGAR | — |
| 2026-01-08 | 0001140361-26-000615 | EDGAR | — |
| 2025-12-19 | 0001140361-25-046187 | EDGAR | — |
| 2025-11-12 | 0001140361-25-041544 | EDGAR | — |
| 2025-11-06 | 0001140361-25-040796 | EDGAR | — |
| 2025-11-06 | 0001140361-25-040675 | EDGAR | — |
| 2025-09-30 | 0001140361-25-036637 | EDGAR | — |
| 2025-09-02 | 0001140361-25-033668 | EDGAR | — |
351 total filings indexed. 319 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001228627 |
| Ticker | IRD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.opusgtx.com |
| Listed | 2020-11-06 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report